These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9277860)

  • 1. [Anemia of end-stage renal disease (ESRD)].
    Osaka N; Kawaguchi Y
    Ryoikibetsu Shokogun Shirizu; 1997; (17 Pt 2):58-61. PubMed ID: 9277860
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin resistance in the treatment of the anemia of chronic renal failure.
    Priyadarshi A; Shapiro JI
    Semin Dial; 2006; 19(4):273-8. PubMed ID: 16893403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease.
    Fishbane S
    Blood Purif; 2007; 25(1):53-7. PubMed ID: 17170538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does early anemia correction prevent complications of chronic renal failure?
    Drüeke TB; Eckardt KU; Frei U; Jacobs C; Kokot F; McMahon LP; Schaefer RM
    Clin Nephrol; 1999 Jan; 51(1):1-11. PubMed ID: 9988140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Requirement for blood in hemodialyzed patients with chronic renal failure in the period before and after introduction to erythropoietin (r-HuEPO) treatment].
    Wiecek A; Kokot F; Spiechowicz U; Cieplok J; Czerwieńska B; Strzelczyk P; Dyjas R
    Przegl Lek; 1996; 53(12):866-9. PubMed ID: 9163010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonhematologic complications of erythropoietin therapy.
    Zhu X; Perazella MA
    Semin Dial; 2006; 19(4):279-84. PubMed ID: 16893404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What are the aims and targets of renal anemia therapy?].
    Eckardt KU
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
    Kawabata M; Kasuga S; Hara H; Suyama S; Moriyama K; Takabatake T
    Clin Nephrol; 2001 Mar; 55(3):265-6. PubMed ID: 11316253
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of anemia in peritoneal dialysis patients.
    Lacson E; Diaz-Buxo JA
    Clin Nephrol; 2001 Dec; 56(6):415-27. PubMed ID: 11770793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin and its use in renal failure.
    Sulková S; Krajhanzl A
    EDTNA ERCA J; 1996; 22(1):suppl 1-7; quiz 8. PubMed ID: 10723310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia management in chronic kidney disease: what have we learned after 17 years?
    Spiegel DM
    Semin Dial; 2006; 19(4):269-72. PubMed ID: 16893402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complications suffered by dialysis patients. 4. Hematologic problems].
    Akizawa T; Shiizaki K
    Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1366-71. PubMed ID: 11032504
    [No Abstract]   [Full Text] [Related]  

  • 13. [Favourable effects of the treatment of renal anemia in early stage chronic renal failure].
    Kes P
    Lijec Vjesn; 2002; 124(3-4):108-9. PubMed ID: 18956830
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that the anemia of renal failure participates in overall uremic toxicity.
    Kokot F; Wiecek A
    Kidney Int Suppl; 1997 Nov; 62():S83-6. PubMed ID: 9350689
    [No Abstract]   [Full Text] [Related]  

  • 15. [Case of early pronounced anemia and its effective treatment with human recombinant erythropoietin in a female patient with polycystic kidney in a conservative stage of chronic renal failure].
    Alekseeva TB; Nikolaev AIu; Trofimova EI
    Ter Arkh; 1999; 71(6):70-1. PubMed ID: 10420463
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anemia in chronic renal failure and erythropoietin].
    Rosenlöf K
    Duodecim; 1995; 111(15):1489-95. PubMed ID: 9244705
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of epoetin zeta for correction of renal anemia in hemodialysis patients with thalassemia minor.
    Kumchev E; Koytchev R; Dimitrakov D; Stavrev P; Tsochev G; Siebert-Weigel M
    Adv Ther; 2008 Dec; 25(12):1375-8. PubMed ID: 19043680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Should anemia be completely corrected in patients with chronic renal failure?].
    Kes P; Brunetta B
    Lijec Vjesn; 2002; 124(6-7):225-7. PubMed ID: 19658341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of erythropoietin to treat anaemia in end-stage renal disease.
    Ellis P; Ellis JA
    Prof Nurse; 1995 Apr; 10(7):448-50. PubMed ID: 7724635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to optimize the concept of the variability of haemoglobin in dialysis patients].
    Kessler M
    Nephrol Ther; 2008 Dec; 4(7):547-8. PubMed ID: 18809370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.